1 Market Outlook India Research August 26, 2011 Please refer to important disclosures at the end of this report Sebi Registration No: INB 010996539 Dealer’s Diary The key benchmark indices pared gains soon after a firm start triggered by a rally in Asian shares and swung between gains and losses in morning trade. The market extended losses to hit fresh intraday low in mid-morning trade but trimmed losses in early afternoon trade. The recovery gathered steam in afternoon trade as European shares rose in early trade and the market regained positive terrain for a brief period. Volatility ruled the roost as the market trimmed losses after weakening once again in mid-afternoon trade. The market extended losses in the late trade as food inflation rose and traders rolled over positions in the derivatives segment from the near-month August 2011 series to September 2011 series with Sensex and Nifty closing down by0.9% and1.0%, respectively. The mid-cap and small cap indices closed down by 0.9% and 0.8%, respectively. Among the front runners, DLF, Tata Motors, Sun Pharma, Bharti Airtel and ONGC gained 1-3% while, Jindal Steel, Jaiprakash Associates, Hero MotoCorp, Infosys and HDFC lost 3-5%. Among mid-caps, Sujana Towers, Tube investments, Standard Chartered, GTL Infra and Fortis gained 5-7% while, Deccan Chronicle, Ballarpur Industries, BGREnergy, Manappuram Finance and India Cements lost 5-7%. Markets Today The trend deciding level for the day is 16,208/4,860 levels. If NIFTY trades above this level during the first half-an-hour of trade then we may witness a further rally up to 16,312–16,478/4,895–4,951 levels. However, if NIFTY trades below 16,208/4,860 levels for the first half-an-ho ur of trade then it maycorrect up to 16,043–15,939/4,804–4,769 levels. Indices S2 S1 R1 R2 SENSEX 15,939 16,043 16,312 16,478 NIFTY 4,769 4,804 4,895 4,951 News Analysis L&T bags orders worth `797cr Aventis Pharma acquires Universal Medicare Refer detailed news analysis on the following page Net Inflows (August 24, 2011) ` cr Purch Sales Net MTD YTD FII 2,006 2,764 (758) (9,114) (381) MFs 451 357 94 2,030 5,807 FII Derivatives (August 25, 2011) ` crPurch Sales Net Open Interest Index Futures 5,103 5,282 (180) 11,183 Stock Futures 7,027 6,645 382 25,587 Gainers / Losers Gainers Losers Company Price ( `) chg (%) Company Price (`) chg (%) Idea Cellular 98 5.0 JP Power 33 (8.3) Colgate Palmolive 964 3.7 Mphasis 368 (7.1) ABB 809 3.5 GMR Infra 27 (6.8) Lupin 463 3.0 Mannapuram Finance 45 (5.6) LIC Housing Fin 206 2.9 Lanco Infra 16 (5.4) Domestic Indices Chg (%) (Pts) (Close) BSE Sensex (0.9) (138.7) 16,146 Nifty(1.0) (49.3) 4,840 MID CAP (0.9) (54.9) 6,174 SMALL CAP (0.8) (59.0) 7,100 BSE HC 0.3 19.6 5,889 BSE PSU (0.6) (48.8) 7,652 BANKEX (1.4) (149.7) 10,508 AUTO (0.2) (14.7) 8,105 METAL (1.9) (219.3) 11,572 OIL & GAS (0.5) (40.7) 8,289 BSE IT (2.1) (100.0) 4,737 Global Indices Chg (%) (Pts) (Close) Dow Jones (1.5) (170.9) 11,150 NASDAQ (2.0) (48.1) 2,420 FTSE (1.4) (74.8) 5,131 Nikkei 1.5 132.8 8,772 Hang Seng 1.5 285.7 19,753 Straits Times 1.7 45.8 2,766 Shanghai Com 2.9 74.2 2,615 Indian ADRs Chg (%) (Pts) (Close) Infosys (3.7) (1.9) $47.7 Wipro (2.0) (0.2) $9.5 ICICI Bank (3.3) (1.2) $35.9 HDFC Bank (3.2) (1.0) $30.4 Advances / Declines BSE NSE Advances 1,138 47 Declines 1,638 942 Unchanged 122 58 Volumes (` cr) BSE 2,438 NSE 13,388
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Please refer to important disclosures at the end of this report Sebi Registration No: INB 010996539
Dealer’s Diary
The key benchmark indices pared gains soon after a firm start triggered by arally in Asian shares and swung between gains and losses in morning trade.
The market extended losses to hit fresh intraday low in mid-morning trade buttrimmed losses in early afternoon trade. The recovery gathered steam inafternoon trade as European shares rose in early trade and the marketregained positive terrain for a brief period. Volatility ruled the roost as themarket trimmed losses after weakening once again in mid-afternoon trade.The market extended losses in the late trade as food inflation rose and tradersrolled over positions in the derivatives segment from the near-month August2011 series to September 2011 series with Sensex and Nifty closing down by 0.9% and1.0%, respectively. The mid-cap and small cap indices closed downby 0.9% and 0.8%, respectively. Among the front runners, DLF, Tata Motors,Sun Pharma, Bharti Airtel and ONGC gained 1-3% while, Jindal Steel,Jaiprakash Associates, Hero MotoCorp, Infosys and HDFC lost 3-5%. Among
mid-caps, Sujana Towers, Tube investments, Standard Chartered, GTL Infraand Fortis gained 5-7% while, Deccan Chronicle, Ballarpur Industries, BGR Energy, Manappuram Finance and India Cements lost 5-7%.
Markets Today
The trend deciding level for the day is 16,208/4,860 levels. If NIFTY tradesabove this level during the first half-an-hour of trade then we may witness afurther rally up to 16,312–16,478/4,895–4,951 levels. However, if NIFTYtrades below 16,208/4,860 levels for the first half-an-hour of trade then it may correct up to 16,043–15,939/4,804–4,769 levels.
Larsen & Toubro’s (L&T) building and factories division has bagged orders aggregating to ` 797cr from one of the leading developers. The order is for mixed use constructioncomprising predominantly of residential, including retail and commercial developments atMumbai. With these order the outstanding order book stands at ~ ` 1.38 trillion (3.1x
FY2011 revenues) providing revenue visibility for next couple of years.
At the CMP of ` 1,547, the stock is trading at 19.4x FY2013E earnings and 3.3x FY2013EP/BV, on a standalone basis. We have used the sum-of-the-parts (SOTP) methodology tovalue the company to capture all its business initiatives and investments/stakes in thedifferent businesses. Ascribing separate values to its parent business on a P/E basis andinvestments in subsidiaries on P/E, P/BV and mcap basis, our target price works out to ` 1,946, which provides 25.8% upside from current levels. We recommend a Buy on thestock and maintain L&T as our top pick in the sector.
Aventis Pharma acquires Universal Medicare
Aventis has acquired Universal Medicare, a nutraceutical formulation company. Accordingto the deal, the products that Aventis Pharma will be acquiring on mutually agreed termsand the manufacturing rights of the company would be retained by the UniversalMedicare. Mumbai-based Universal Medicare manufactures markets and distributesbranded nutraceutical formulations in India through its sales and marketing infrastructure.For the year ended 31 March 2011, the company's turnover of branded nutraceuticalformulations was approximately Rs110cr. The latest acquisition, the company will advanceits sustainable growth strategy in India and facilitate the creation of a consumer healthcareand wellness platform. This move is also synergetic with the growth strategy of Sanofi, amajority stakeholder in Aventis Pharma. The transaction is expected to close by 4QDec’2011. While the details of the deal are not know, we believe that the earnings
would increase by 7%. Thus after factoring in the possible upsides from the deal, the stockwould trade at 21.6xCY2012E earnings, and hence remain Neutral on the stock.
Economic and Political News
Citigroup cuts global, India growth view
Food inflation soars to 9.8% from 9.03%
Government to relax equity dilution norms for insurance firms
India, China enjoy 68% of emerging market PE investment
Corporate News
ONGC looks to drill eight wells in KG gas block
Srei Infra Finance to raise ` 4,600cr infra fund
Tata Power to invest ` 1,000cr to lay cables in Mumbai
Telcos under TRAI scanner for hiking mobile tariffs
Source: Economic Times, Business Standard, Business Line, Financial Express, Mint
Research Team Tel: 022-3935 7800 E-mail: [email protected] Website: www.angelbroking.com
DISCLAIMER
This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment
decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make
such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies
referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits andrisks of such an investment.
Angel Broking Limited, its affiliates, directors, its proprietary trading and investment businesses may, from time to time, make investment
decisions that are inconsistent with or contradictory to the recommendations expressed herein. The views contained in this document are
those of the analyst, and the company may or may not subscribe to all the views expressed within.
Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and
trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's
fundamentals.
The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources
believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for
general guidance only. Angel Broking Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss ordamage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Limited has
not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation
or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Limited
endeavours to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other
reasons that prevent us from doing so.
This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced,
redistributed or passed on, directly or indirectly.
Angel Broking Limited and its affiliates may seek to provide or have engaged in providing corporate finance, investment banking or other
advisory services in a merger or specific transaction to the companies referred to in this report, as on the date of this report or in the past.
Neither Angel Broking Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or inconnection with the use of this information.
Note: Please refer to the important ‘Stock Holding Disclosure' report on the Angel website (Research Section). Also, please refer to thelatest update on respective stocks for the disclosure status in respect of those stocks. Angel Broking Limited and its affiliates may haveinvestment positions in the stocks recommended in this report.
Angel Broking Ltd: BSE Sebi Regn No : INB 010996539 / CDSL Regn No: IN - DP - CDSL - 234 - 2004 / PMS Regn Code: PM/INP000001546